Focusing on the integration of production and talent to develop the list of scientific and technological enterprises in Jiangsu biomedical industry

[China Pharmaceutical network industry trends] recently, Jiangsu Province announced the list of small and medium-sized technology-based enterprises to be warehoused in 2018, with 2813 enterprises approved It is reported that the technology-based small and medium-sized enterprises entered the warehouse this time cover electronic information, communication, biomedicine, new materials, energy conservation and environmental protection, optical mechanical and electrical integration and other fields As one of the important emerging strategies, biomedicine plays an important role in promoting the transformation and upgrading of small and medium-sized enterprises to science and technology-based enterprises in Jiangsu Province "Strive to speed up the construction of industrial system of coordinated development of real economy, scientific and technological innovation, modern finance and human resources" As the forefront of China's biomedical industry, Jiangsu Province focuses on the integration of biomedical industry and talent development, strengthens the linkage between industrial departments and talent departments, and constantly optimizes the talent introduction mechanism For example, through the implementation of the "113 special plan for medical talents", Taizhou city has gathered more than 3000 high-level talents at home and abroad in China Pharmaceutical City, including 5 academicians of the "two academies", 2 foreign academicians, 100 provincial "entrepreneurship and innovation" talents, and 8 provincial "entrepreneurship and innovation" teams, not only forming the high-level talents gathering highland of biomedical medicine, but also becoming a new landmark of the province's biomedical industry, the pharmaceutical industry The value accounts for 39.1% of the province With the vigorous promotion of policies and the promotion of the integration of industry and talent, Jiangsu's biomedical industry has been greatly developed Some insiders said, "in 2017, the total value of the biomedical industry in Suzhou Industrial Park has exceeded 60 billion, and the number of enterprises has exceeded 1000 Among them, the number of medical and gene testing enterprises has been close to 100, which has formed a certain scale and brand effect " In addition, the author also learned that recently Jiangsu breast bioreactor pharmaceutical project and transgenic animal drug research institute project were officially settled The so-called mammary gland bioreactor pharmaceutical project, which takes gene engineering technology as the core, introduces the gene of medical and health care effect into the animal body, so that the exogenous gene can be expressed in the mammary gland of the animal, thus producing various kinds of drugs with medicinal value This new mode of biopharmaceutical production has the advantages of low cost, high efficiency and high yield After more than ten years' efforts, Zeng Yitao's team has cultivated animal milk with specific genes (genes with medicinal efficacy), extracted medicinal proteins, and achieved the purpose of mass production of various drugs, especially the pharmaceutical proteins needed for scarce drugs Biomedicine, intelligent robot, 3D printing, Internet of things, nanotechnology These emerging industries, which are rising and will become "prominent", are important factors in a country's comprehensive national strength competition, and also determine whether the country can take the lead in the global competition in the future For the development of biomedical industry, Jiangsu has carried out in-depth research and drawn a "industrial talent map" The author has learned that the development of biomedical industry in Jiangsu Province has a high proportion in China According to relevant data statistics, in 2016, the main business income of Jiangsu pharmaceutical industry was 450 billion yuan, an increase of 28.55% year on year; the total profit was 48.957 billion yuan, an increase of 34.91% year on year The proportion of total output value of pharmaceutical industry in the top three cities continued to expand, accounting for 74.15% of the total output value of pharmaceutical industry in Jiangsu Province, namely Taizhou (39.08%), Lianyungang (23.10%) and Nanjing (11.97%) Jiangsu pharmaceutical enterprises are mainly distributed in Nanjing, Suzhou, Taizhou and Lianyungang Jiangsu has the advantage of human resources In 2015, Jiangsu Province's pharmaceutical manufacturing industry had 549 scientific research institutions, surpassing other provinces, ranking first for five consecutive years In 2015, there were 167557 scientific researchers in the pharmaceutical manufacturing industry in China, including 21950 in Jiangsu, accounting for 13.1%, ranking the second in China In addition, the research and development capacity of biomedicine in Jiangsu University is in the forefront of the country Among them, China Pharmaceutical University has the National Key Laboratory of "active components and efficacy of natural drugs", 18 national and ministerial key laboratories, technical platforms and engineering technology centers related to each node of preclinical innovative drug research and development, as well as "Pharmaceutical Research Institute" In the future, we will continue to promote the deep integration of industrial development and talent development, and create a new model of biomedical industry talent integration Some experts said that in the future, Jiangsu will further carry out talent project cooperation, break through the bottleneck of core technology, achieve the goal of "introducing an expert or team to break through a key technology", and strive to break through the bottleneck of new target chemical drugs, antibody drugs, peptide drugs, new vaccines and other production technologies We will further expand the channels for the introduction of foreign experts in Jiangsu Province, take advantage of the opportunities of scientific and cultural exchanges with foreign countries and visits to sister cities, and introduce foreign senior R & D experts in the field of biomedicine to work in Jiangsu through high salary recruitment, technology investment and other forms.